![Mark Lackner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lackner
No más puestos en curso
Fortuna: 779 260 $ al 31/08/2026
Perfil
Mark Lackner worked at Genentech, Inc. from 2012 to 2018, serving as Director from 2015 to 2018.
From 2018 to 2022, worked at IDEAYA Biosciences, Inc. as SVP, Head-Biology & Translational Sciences.
From 2022 to 2025, worked at Zentalis Pharmaceuticals, Inc. as Chief Scientific Officer from 2023 to 2025.
Education includes a doctorate from Stanford University conferred in 1997, an undergraduate degree from the University of Illinois At Urbana–Champaign in 1990, and a graduate degree from the same institution in 1991.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/04/2026 | 207.250 ( 0,22 % ) | 779 260 $ | 31/08/2026 |
Antiguos cargos conocidos de Mark Lackner.
| Empresas | Cargo | Fin |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/04/2025 |
| IDEAYA BIOSCIENCES, INC. | Corporate Officer/Principal | 01/10/2022 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Director/Miembro de la Junta | 01/05/2018 |
Formación de Mark Lackner.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
96
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
- Bolsa de valores
- Insiders
- Mark Lackner
